10% Owner · Evommune, Inc. · Evommune, Inc. — Series A Preferred Stock
Side
C
Value
—
Shares
15.49M
Price
—
Executed
Nov 7, 2025
Disclosed
Nov 12, 2025
Disclosure timeline5 days from execution to publication · legal deadline 2 business days
Nov 7 executedNov 12, 2025 disclosed
EVMN · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Derivative conversion — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing+6 / 15
Disclosed 3 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
LSP 7 Cooperative UA filed this Form 4 reporting a derivative conversion of EVMN on Nov 7, 2025. It became public on Nov 12, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
10% Owner
LSP 7 Cooperative UAcik:0001876264
Issuer
Evommune, Inc.cik:0002044725
Revision history · 0
No field has changed since this record was first ingested.
